Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT03096327
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of Asthma
* Signed Informed Consent
Exclusion Criteria:
* Previous adverse reaction to montelukast or other leukotriene inhibitor;
* History of hyper-eosinophilic disorder other than atopic disease;
* Treatment with montelukast within 4 weeks from randomization;
* Asthma exacerbation or treatment with prednisone/other systemic steroid within 4 weeks from randomization.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT03096327
Study Brief:
Protocol Section:
NCT03096327